Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Therapeutics Pipeline Report H1 2017 - Review of 14 Companies & Drug Profiles Including Celgene, Merck & Pfizer - Research and Markets
Company Profile for MuleSoft
Top Leaders in Beauty and Retail Honored at the 2017 Outstanding Mother Awards
Wellbeing Beauty Brand, Philosophy and Its Hope & Grace Initiative, Kick off Mental Health Month with “How Are You, Really?” PSA and National Campaign
As macro headwinds mount, we would look for a larger valuation discount among consumer cyclical names.
As the risk of increasing inflation looms, the risk/reward opportunity in stocks does not signal a screaming buy to us at this point.
The U.S. economy is in decent shape, but we are being even more selective given recent outperformance.